228 related articles for article (PubMed ID: 34771464)
1. Gram-Negative Bacterial Lipopolysaccharide Promotes Tumor Cell Proliferation in Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Mempin M; Hu H; Vickery K; Kadin ME; Prince HM; Kouttab N; Morgan JW; Adams WP; Deva AK
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771464
[TBL] [Abstract][Full Text] [Related]
2. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
3. What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?
Lajevardi SS; Rastogi P; Isacson D; Deva AK
JPRAS Open; 2022 Jun; 32():34-42. PubMed ID: 35242986
[TBL] [Abstract][Full Text] [Related]
4. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research.
Deva AK; Turner SD; Kadin ME; Magnusson MR; Prince HM; Miranda RN; Inghirami GG; Adams WP
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371292
[TBL] [Abstract][Full Text] [Related]
5. The Role of Microorganisms in the Development of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Alessandri-Bonetti M; Jeong T; Vaienti L; De La Cruz C; Gimbel ML; Nguyen VT; Egro FM
Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839585
[TBL] [Abstract][Full Text] [Related]
6. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
7. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
8. Our Experience in Diagnosing and Treating Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Shoham G; Haran O; Singolda R; Madah E; Magen A; Golan O; Menes T; Arad E; Barnea Y
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256500
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Microbiome of Breast Implants and Periprosthetic Tissue in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Walker JN; Hanson BM; Pinkner CL; Simar SR; Pinkner JS; Parikh R; Clemens MW; Hultgren SJ; Myckatyn TM
Sci Rep; 2019 Jul; 9(1):10393. PubMed ID: 31316085
[TBL] [Abstract][Full Text] [Related]
10. Implant replacement and anaplastic large cell lymphoma associated with breast implants: a quantitative analysis.
Vittorietti M; Mazzola S; Costantino C; De Bella DD; Fruscione S; Bonaccorso N; Sciortino M; Costanza D; Belluzzo M; Savatteri A; Tramuto F; Contiero P; Tagliabue G; Immordino P; Vitale F; Di Napoli A; Mazzucco W
Front Oncol; 2023; 13():1202733. PubMed ID: 37927474
[TBL] [Abstract][Full Text] [Related]
11. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
12. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).
Lee JH
Yeungnam Univ J Med; 2021 Jul; 38(3):175-182. PubMed ID: 33461261
[TBL] [Abstract][Full Text] [Related]
13. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
14. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management.
St Cyr TL; Pockaj BA; Northfelt DW; Craig FE; Clemens MW; Mahabir RC
Plast Surg (Oakv); 2020 May; 28(2):117-126. PubMed ID: 32596187
[TBL] [Abstract][Full Text] [Related]
15. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in Poland: analysis of patient series and practical guidelines for breast surgeons.
Pluta P; Giza A; Kolenda M; Fendler W; Braun M; Chudobiński C; Chałubińska-Fendler J; Araszkiewicz M; Loga K; Lembas L; Witkowska M; Pluta A; Kolasiński J; Basta P; Kołacińska-Voytkuv A; Cieśla S; Jesionek-Kupnicka D; Jankau J; Kuczyński M; Kalinka E; Zadrożny M; Murawa D
Arch Med Sci; 2023; 19(5):1243-1251. PubMed ID: 37732037
[TBL] [Abstract][Full Text] [Related]
16. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
17. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
18. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
19. Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Wang Y; Zhang Q; Tan Y; Lv W; Zhao C; Xiong M; Hou K; Wu M; Ren Y; Zeng N; Wu Y
Front Oncol; 2021; 11():785887. PubMed ID: 35070989
[TBL] [Abstract][Full Text] [Related]
20. Current risk of breast implant-associated anaplastic large cell lymphoma: a systematic review of epidemiological studies.
Lynch EB; DeCoster RC; Vyas KS; Rinker BD; Yang M; Vasconez HC; Clemens MW
Ann Breast Surg; 2021; 5():. PubMed ID: 35415602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
